Product
RC1012
1 clinical trial
1 indication
Indication
Acute Myeloid LeukemiaClinical trial
A Single-arm, Single/Multiple Dose-escalation and Dose-extension Phase I Clinical Trial of RC1012 Injection (Allogeneic DNT Cells) in Patients With Relapsed/Refractory Acute Myeloid LeukemiaStatus: Recruiting, Estimated PCD: 2023-12-31